European Journal of Drug Metabolism and Pharmacokinetics
Impact Factor Trend (2018–2026)
Clarivate IF trend for European Journal of Drug Metabolism and Pharmacokinetics
SCImago Journal Rank citation prestige weighting
52 papers with at least that number of citations each
Aims & Scope
Hepatology International is a peer-reviewed journal featuring articles written by clinicians, clinical researchers and basic scientists is dedicated to research and patient care issues in hepatology. This journal focuses mainly on new and emerging diagnostic and treatment options, protocols and molecular and cellular basis of disease pathogenesis, new technologies, in liver and biliary sciences. Hepatology International publishes original research articles related to clinical care and basic research; review articles; consensus guidelines for diagnosis and treatment; invited editorials, and controversies in contemporary issues. The journal does not publish case reports.
Special Issues
Calls for PapersNo active Calls for Papers found for this journal.
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
PHARMACOLOGY & PHARMACY
PHARMACOLOGY & PHARMACY
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Journal Metrics & Citation Visualizations
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Academic Intelligence Overview & Context
ImpaQ AnalysisEuropean Journal of Drug Metabolism and Pharmacokinetics (acronym: ejdr, abbr: EUR J DRUG METAB PH, ISSN: 0378-7966) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer International Publishing in Switzerland since 1976. The periodical holds a Journal Impact Factor (JIF) of 2.30, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.632 (Q2), an H-index of 52.
The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 69 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,000 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics